Valstar
Valrubicin (N-trifluoroacetyladriamycin-14-valerate, Valstar®) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder.
Dosage
800 mg weekly for 6 weeks
Side effects
- Blood in urine
- Incontinence
- painful or difficult urination
- Unusually frequent urination
Contact
Home
A
Hydrocodone